Competing interests
All authors have completed the ICMJE uniform disclosure form at
www.icmje.org/coi_disclosure.pdf and declare: grants from UK Medical
Research Council, NIHR/Imperial BRC and UK Food Standards Agency for the
submitted work. MRG is now employed by Laboratorios Leti, this occurred
followed data lock and completion of study analyses. SRD reports grants
from the Immune Tolerance Network, National Institute of Allergy and
Infectious Diseases, ALK-Abelló, Regeneron, and Biotech Tools outside
the submitted work; personal fees from Anergis, Circassia, Biomay,
Merck, Allergy Therapeutics, Med Update GmbH, and Food Standards Agency.
RJB reports personal fees from Prota Therapeutics, DBV Technologies,
Cochrane Collaboration, John Wiley & Sons on behalf of Clinical and
Experimental Allergy, personal fees from giving expert testimony,
outside the submitted work. ENCM reports grants from the UK Biological
and Biotechnological Sciences Research Council, DBV Technologies, Reacta
Biotech, the Medical Research Council, the European Union, and the UK
Food Standards Agency and has patents pending to Reacta Biotech Ltd
(PCT/GB2016/051637 and PCT/GB2016/053829). PJT reports grants from UK
Food Standards Agency, JM Charitable Foundation and End Allergies
Together, outside the submitted work; personal fees from UK Food
Standards Agency, DBV Technologies, Aimmune Therapeutics, Allergenis and
ILSI Europe outside the submitted work. All other authors declare no
competing interests.